Cibc Private Wealth Group, LLC Intellia Therapeutics, Inc. Transaction History
Cibc Private Wealth Group, LLC
- $53.9 Billion
- Q3 2024
A detailed history of Cibc Private Wealth Group, LLC transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 8,382 shares of NTLA stock, worth $82,059. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,382
Previous 5,880
42.55%
Holding current value
$82,059
Previous $131,000
31.3%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding NTLA
# of Institutions
324Shares Held
91.5MCall Options Held
442KPut Options Held
880K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl12.5MShares$123 Million1.28% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.63MShares$94.3 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.6MShares$94 Million0.0% of portfolio
-
State Street Corp Boston, MA5.14MShares$50.4 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.95MShares$48.5 Million3.75% of portfolio
About Intellia Therapeutics, Inc.
- Ticker NTLA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,011,800
- Market Cap $744M
- Description
- Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...